Cryo-Cell International Statistics
Total Valuation
CCEL has a market cap or net worth of $67.30 million. The enterprise value is $76.91 million.
Important Dates
The next estimated earnings date is Tuesday, December 3, 2024, after market close.
| Earnings Date | Dec 3, 2024 |
| Ex-Dividend Date | Nov 15, 2024 |
Share Statistics
CCEL has 8.06 million shares outstanding. The number of shares has decreased by -2.65% in one year.
| Current Share Class | 8.06M |
| Shares Outstanding | 8.06M |
| Shares Change (YoY) | -2.65% |
| Shares Change (QoQ) | -0.71% |
| Owned by Insiders (%) | 37.70% |
| Owned by Institutions (%) | 6.12% |
| Float | 3.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 75.91 |
| PS Ratio | 2.15 |
| Forward PS | 1.99 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 21.80 |
| P/OCF Ratio | 9.35 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 119.92, with an EV/FCF ratio of 24.91.
| EV / Earnings | n/a |
| EV / Sales | 2.42 |
| EV / EBITDA | 119.92 |
| EV / EBIT | n/a |
| EV / FCF | 24.91 |
Financial Position
The company has a current ratio of 0.61
| Current Ratio | 0.61 |
| Quick Ratio | 0.52 |
| Debt / Equity | n/a |
| Debt / EBITDA | 10.83 |
| Debt / FCF | 3.80 |
| Interest Coverage | -0.18 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -0.13% |
| Return on Capital (ROIC) | -1.19% |
| Revenue Per Employee | $361,801 |
| Profits Per Employee | -$101,435 |
| Employee Count | 88 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 13.51 |
Taxes
| Income Tax | -3.42M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +92.84% in the last 52 weeks. The beta is 0.51, so CCEL's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | +92.84% |
| 50-Day Moving Average | 6.95 |
| 200-Day Moving Average | 7.18 |
| Relative Strength Index (RSI) | 59.25 |
| Average Volume (20 Days) | 42,659 |
Short Selling Information
The latest short interest is 9,453, so 0.12% of the outstanding shares have been sold short.
| Short Interest | 9,453 |
| Short Previous Month | 9,397 |
| Short % of Shares Out | 0.12% |
| Short % of Float | 0.25% |
| Short Ratio (days to cover) | 0.59 |
Income Statement
In the last 12 months, CCEL had revenue of $31.84 million and -$8.93 million in losses. Loss per share was -$1.09.
| Revenue | 31.84M |
| Gross Profit | 19.71M |
| Operating Income | -139,445 |
| Pretax Income | -12.66M |
| Net Income | -8.93M |
| EBITDA | 641,301 |
| EBIT | -139,445 |
| Loss Per Share | -$1.09 |
Full Income StatementBalance Sheet
The company has $2.13 million in cash and $11.73 million in debt, giving a net cash position of -$9.60 million or -$1.19 per share.
| Cash & Cash Equivalents | 2.13M |
| Total Debt | 11.73M |
| Net Cash | -9.60M |
| Net Cash Per Share | -$1.19 |
| Equity (Book Value) | -9.56M |
| Book Value Per Share | -1.19 |
| Working Capital | -6.76M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $7.20 million and capital expenditures -$4.11 million, giving a free cash flow of $3.09 million.
| Operating Cash Flow | 7.20M |
| Capital Expenditures | -4.11M |
| Free Cash Flow | 3.09M |
| FCF Per Share | $0.38 |
Full Cash Flow StatementMargins
Gross margin is 61.92%, with operating and profit margins of -0.44% and -28.04%.
| Gross Margin | 61.92% |
| Operating Margin | -0.44% |
| Pretax Margin | -38.78% |
| Profit Margin | -28.04% |
| EBITDA Margin | 2.01% |
| EBIT Margin | -0.44% |
| FCF Margin | -1.62% |